Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

For patients with relapsed or refractory hairy-cell leukemia

Vemurafenib Deemed Highly Effective in Hairy-Cell Leukemia

0
Findings from two phase 2 studies in Italy and United States show short oral course is highly effective
Additional data supports daily pre-exposure prophylaxis for HIV-negative gay men at high risk for infection. The findings were reported online Sept. 9 in The Lancet.

Supportive Evidence for Daily PrEP Curbing HIV Transmission

0
This preventive treatment should be routinely offered to gay men at high risk, researchers say
The number of pediatric emergency department visits for medication exposures in children aged 6 years and younger rose during the early 2000s

CDC: ER Visits for Medication Overdoses in Children Down

0
Four meds caused 91.2 percent of visits for over-the-counter liquid medication exposures
Two newly approved medications to treat high cholesterol are extremely overpriced compared to the health benefits they give to patients

ICER: New Cholesterol Drugs Highly Overpriced

0
Newly FDA-approved Repatha and Praluent currently cost more than $14,000 per year
Imetelstat

Imetelstat Deemed Active in Myelofibrosis, Thrombocythemia

0
Responses for patients with myelofibrosis, essential thrombocythemia
None of 657 patients who took a daily pill to prevent HIV infection contracted the virus over a period of more than two years

Daily PrEP Prevents HIV Infection in High-Risk Individuals

0
Study participants were infected with other sexually transmitted diseases
For patients with diabetic nephropathy receiving an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker

Finerenone Linked to Improved UACR in Diabetic Nephropathy

0
Addition of finerenone to ACE inhibitor or ARB tied to reduction in urinary albumin-creatinine ratio
For patients with rheumatoid arthritis with prior biologic exposure

Study Compares Hospitalized Infection Risk for Biologics in RA

0
Risk of hospitalized infection increased with etanercept, infliximab, rituximab versus abatacept
For patients with established Chagas' cardiomyopathy

Benznidazole Tx Explored in Chagas’ Cardiomyopathy

0
Reduces serum parasite detection but does not reduce cardiac clinical deterioration through 5 years
For patients with an acute coronary syndrome undergoing percutaneous coronary intervention

Bivalirudin Doesn’t Lower Major Cardiovascular Event Rate in ACS

0
No decrease in rate of major CV events, net adverse clinical events for patients undergoing PCI